Copyright © 2006, European Society of Cardiology
Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: Role of NADPH oxidase
aUMR CNRS 7175, Pharmacologie et Physico-Chimie, 67401 Illkirch, France
bLaboratoire de Pharmacologie, de Pharmacodynamie et de Physiologie, Faculté de Médecine et de Pharmacie, Dakar, Senegal
cResearch and Development Center, Yangji Chemicals, An-San, South Korea
dLaboratoire de Pharmacologie, INSERM E356, Université Victor Segalen, 33076 Bordeaux, France
* Corresponding author. UMR CNRS 7175, Département Pharmacologie et Physico-Chimie, 74, route du Rhin, 67401 Illkirch, France. Tel.: +33 3 90 24 41 27; fax: +33 3 90 24 43 13. Email address: valerie.schini-kerth{at}pharma.u-strasbg.fr
Received 25 October 2005; revised 23 May 2006; accepted 24 May 2006
| Abstract |
|---|
|
|
|---|
Objective: Chronic administration of moderate amounts of red wine has been associated with a protective effect on the cardiovascular system. This study examined whether red wine polyphenols prevent the angiotensin II (Ang II)-induced hypertension and endothelial dysfunction in rats, and, if so, to elucidate the underlying mechanism.
Methods Hypertensive rats were obtained by a 14-day infusion of Ang II. Red wine polyphenols were administered in the drinking water one week before and during the Ang II infusion. Arterial pressure was measured in conscious rats. Ex vivo vascular relaxation was assessed in organ chambers, vascular superoxide anion production by dihydroethidine and vascular NADPH oxidase expression by immunohistochemistry.
Results: Ang II-induced hypertension was associated with decreased relaxation to acetylcholine but not to red wine polyphenols. The Ang II treatment also increased vascular superoxide anion production and expression of nox1 and p22phox NADPH oxidase subunits. Intake of red wine polyphenols prevented the Ang II-induced hypertension and endothelial dysfunction and normalized vascular superoxide anion production and NADPH oxidase subunit expression. Red wine polyphenol treatment alone did not affect blood pressure.
Conclusion Intake of red wine polyphenols prevents Ang II-induced hypertension and endothelial dysfunction. Prevention of vascular NADPH oxidase induction and preservation of arterial nitric oxide availability during Ang II administration likely contribute to this effect.
KEYWORDS Angiotensin II; Endothelial function; Hypertension; NADPH oxidase; Redox signaling
| 1. Introduction |
|---|
|
|
|---|
Epidemiological studies have indicated that regular intake of moderate amounts of wine, in particular red wine, is associated with a reduced risk in overall mortality [1,2]. This effect has been attributable to a reduction in death from cardiovascular diseases and cancer [1,2]. Although the alcohol component may contribute to the protective effect by increasing the concentration of high density lipoproteins, and by decreasing the fibrinogen level and the reactivity of platelets [3–5], several recent studies suggest also a key role of the polyphenolic component (for review see: [6,7]). Indeed, intake of red wine polyphenols reduced the development of atherosclerosis in several experimental models of atherosclerosis but was without effect on mature atherosclerosis [8–10]. Red wine polyphenols and a grape skin extract also reduced blood pressure in NG-nitro-L-arginine methyl ester (L-NAME)- and desoxycorticosterone acetate (DOCA) salt-induced hypertensive rats [11,12].
Cardiovascular diseases such as atherosclerosis and hypertension are characterized by an impaired endothelium-dependent relaxation in both animals and humans [13]. Such an endothelial dysfunction is observed early in the development of the pathology and is due, at least in part, to an excessive vascular formation of reactive oxygen species in particular superoxide anions, which reduce the bioavailability of nitric oxide (NO) [14–17]. Although red wine polyphenols have antihypertensive properties, the possibility that they prevent the oxidative stress-induced endothelial dysfunction remains to be determined. Amongst experimental models of hypertension, that induced by angiotensin II (Ang II) has been well characterized and is of potential clinical importance. Indeed, a variety of pathologic states, including certain forms of hypertension, congestive heart failure, and nitrate tolerance, are associated with elevated plasma renin activity and circulating levels of Ang II [18,19]. In transgenic hypertensive rats overexpressing the Ren2 gene and in Ang II-induced hypertensive rats, a marked upregulation of the vascular expression of NADPH oxidase is observed and this effect is associated with an excessive formation of superoxide anions, which, in turn, decreases the bioavailability of endothelium-derived NO [15,20]. Therefore, the aim of the present study was to examine whether chronic intake of red wine polyphenols prevents the Ang II-induced hypertension and endothelial dysfunction, and, if so, to determine the underlying mechanism.
| 2. Methods |
|---|
|
|
|---|
The study conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and has been approved by the local ethics committee.
2.1. Preparation of red wine polyphenolic extract
Red wine phenolic extract dry powder was obtained from French red wine (Corbières A.O.C.) and provided by Dr. M. Moutounet (Institut National de la Recherche Agronomique, Montpellier, France) and analyzed by Dr. P.-L. Teissedre (Département d'Oenologie, Bordeaux, France). The extract was prepared as previously described [21]: briefly, phenolic compounds were adsorbed on a preparative column, then alcohol desorbed; the alcoholic eluent was gently evaporated; the concentrated residue was lyophilized and finely sprayed to obtain the phenolic extract dry powder. One liter of red wine produced 2.9 g of phenolic extract, which contained 471 mg/g of total phenolic compounds expressed as gallic acid. Phenolic levels in phenolic extract were measured by HPLC. The extract contained 8.6 mg/g catechin, 8.7 mg/g epicatechin, dimers (B1: 6.9 mg/g, B2: 8.0 mg/g, B3: 20.7 mg/g and B4: 0.7 mg/g), anthocyanins (malvidin-3-glucoside: 11.7 mg/g, peonidin-3-glucoside: 0.66 mg/g, and cyanidin-3-glucoside: 0.06 mg/g) and phenolic acids (gallic acid: 5.0 mg/g, caffeic acid: 2.5 mg/g, and caftaric acid: 12.5 mg/g).
In vivo treatment of rats
Male Wistar rats (12 to 15 weeks-old) were anesthetized with intraperitoneal ketamine (80 mg/kg) and xylazine (10 mg/kg). A 1-cm incision was made in the midscapular region, and an osmotic minipump (Alzet model 2004) was implanted. Pumps contained Ang II, which was dissolved in 0.15 M NaCl containing 0.01 N acetic acid, and the infusion rate was 0.4 mg/kg/day. Sham-operated rats underwent an identical surgical procedure without pump implantation. After 14 days of Ang II infusion, rats were anesthetized with pentobarbital (60 mg/kg i.p.) and thereafter blood was taken from the abdominal aorta into EDTA-containing tubes and their aortas were harvested. Blood was immediately centrifuged at 4 C for 10 min at 2000 x g. Plasma samples were frozen in liquid nitrogen and stored at – 80 °C until assayed. Red wine polyphenolic extract (150 mg/kg/day, 10% ethanol, pH 3.3) or solvent (10% ethanol, pH 3.3) was given in the drinking water beginning 7 days before Ang II infusion.
2.3. Blood pressure measurement
Systolic blood pressure and heart rate were measured in conscious rats by tail-cuff plethysmography connected to a computerized system (LE 5002®, BIOSEB). Before the administration of red wine polyphenols, the rats were trained in the blood pressure device to accustom them to the procedure for 1 week before the minipump implantation. On each day of blood pressure determination, 10 measurements were obtained and averaged for each rat.
2.4. Vascular reactivity studies
Aortas were cleaned of connective tissue and cut into rings (3–4 mm in length). As indicated the endothelium was removed by rubbing the intimal surface of rings with a pair of forceps. Rings were suspended in organ baths containing oxygenated (95% O2; 5% CO2) Krebs bicarbonate solution (mM: NaCl 119, KCl 4.7, KH2PO4 1.18, MgSO4 1.18, CaCl2 1.25, NaHCO3 25 and D-glucose 11, pH 7.4, 37 °C) for the determination of changes in isometric tension. Following equilibration for 90 min under a resting tension of 2 g, rings were contracted with phenylephrine (1 µM) to about 80% of the maximal contraction reached by increasing concentrations of phenylephrine. After washout and a 30-min equilibration period, rings were contracted again with phenylephrine (1 µM) and the relaxation to acetylcholine (1 µM) was determined. After washout and a 30-minute equilibration period, rings were again contracted with phenylephrine (1 µM) before a concentration–relaxation curve to either red wine polyphenols, acetylcholine or sodium nitroprusside was constructed.
2.5. Determination of plasma renin activity
Plasma renin activity was measured by determining the level of Ang I generated during a 30-min incubation of plasma at 37 °C in the presence of 8-hydroxyquinoline (5 mM). Ang I was measured by radioimmunoassay as previously described [22].
2.6. Determination of vascular reactive oxygen species formation
The oxidative fluorescent dye dihydroethidine was used to evaluate in situ formation of reactive oxygen species by use of a method described by Miller et al. [16]. Aortic rings (3 to 4 mm length) from the control group, the Ang II group, the red wine polyphenols group and the red wine polyphenols plus Ang II group were embedded in OCT compound (Tissue-Tek), and frozen in a pentane/liquid nitrogen bath for cryostat sections. In addition, rings from the Ang II group were also incubated in minimum essential medium containing 0.1% of bovine serum albumin in the absence or presence of an inhibitor for 60 min at 37 °C before being embedded. These unfixed frozen aortic rings were cut into sections 30 µm thick and placed on polylysine-coated-plus glass slides. Dihydroethidine (2.5 µM) was applied to all tissue sections on the slide, which were then incubated in a light-protected humidified chamber at 37 °C for 30 min before being sealed with coverslips. The sections were examined under a confocal microscope (1024 MRC; Bio-Rad, Hercules, CA) with a 60 x epifluorescence objective (Nikon, Tokyo, Japan). After excitation at 488 nm with a Krypton/Argon laser, emission signal was recorded with a Zeiss 565–610 nm filter. Z-series were collected in 3-µm steps from position 0.00 (Z-Start) to 30.00 (Z-Stop). Final images were obtained after stacking. All images were corrected for unspecific fluorescence. Images were analysed by the Confocal AssistantTM (CAS 40 version 4.02, 1024 x 728 Pixels, 32-Bits per Pixels). After a 3-D projection and average of each pixel value, the intensity value of fluorescence was recorded considering an intensity level threshold (Minimum, 0; Maximum, 255).
2.7. Immunohistochemical determination of NADPH oxidase subunit expression
Aortas were removed, embedded in OCT compound, and snap-frozen. Frozen aortas were cryosectioned at 14 µm. Sections were air-dried for 1 h and stored at – 80 °C until use. The slices were first treated with 10% normal serum in PBS containing 0.1% BSA and 0.05% Tween-20 for 45 min to block any nonspecific binding. After rinsing, the sections were then incubated overnight at 4 °C with control nonimmune serum or an antibody directed against either nox1 or p22phox. The antibodies used were a purified goat polyclonal nox1 (sc-5821, 1:100 dilution) and a purified goat polyclonal p22phox (sc-11712, 1:100 dilution). Sections were washed with PBS, incubated with the secondary antibody (donkey anti-goat alexia fluor 567-conjugated, 1:200) diluted in the same buffer for 2 h at room temperature in the dark, and washed before being mounted and coverslipped. Negative controls included omission of primary antibodies.
2.8. Materials
All chemicals were obtained from Sigma Chemical Co unless specified. The superoxide dismutase mimetic [Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin, MnTMPyP] was obtained from Alexis Chemicals and Alzet osmotic minipumps from Charles Rivers Laboratories. Antibodies directed against either nox-1 or p22phox NADPH oxidase proteins were obtained from Santa Cruz.
2.9. Statistical analysis
Values are expressed as mean±S.E.M. Statistical analyses were performed with Student's t-test for unpaired data or by ANOVA followed by the Bonferroni test to compare 2 treatments where appropriate. A value of P<0.05 was considered statistically significant.
3. Results
3.1. Red wine polyphenols prevent the Ang II-induced hypertension
Infusion of Ang II at a rate of 0.4 mg/kg/day to rats caused a significant increase in systolic blood pressure, which reached a steady state plateau 3 days after the start of Ang II infusion and, thereafter, remained elevated throughout the study (Fig. 1A). In contrast to systolic blood pressure, heart rate was unaffected by the Ang II treatment (Fig. 1B). The Ang II-induced elevation in systolic blood pressure was associated with a pronounced reduction of the plasma renin activity (Fig. 1C). Intake of 150 mg/kg/day red wine polyphenols in the drinking water 7 days before the infusion of Ang II significantly reduced the increase in systolic blood pressure (Fig. 1A, F=7.7, P<0.001 Ang II treatment versus RWPs plus Ang II treatment) and the decrease in plasma renin activity induced by Ang II (Fig. 1C). The red wine polyphenols treatment alone affected neither systolic blood pressure nor the plasma renin activity (Fig. 1A and C).
|
3.2. Red wine polyphenols prevent the Ang II-induced endothelial dysfunction
Acetylcholine caused concentration-dependent relaxations in aortic rings with endothelium, which were markedly reduced in the Ang II-treated group compared to the control group (Fig. 2A). In contrast, relaxations to red wine polyphenols in intact aortic rings were only slightly shifted to the right and the maximal relaxation was not impaired in the Ang II-treated group compared to the control group [EC50s (µg/ml) were 3.4±0.9 and 7.8±2.0, respectively, P=0.06; Fig. 2B]. In addition, RWPs did not cause significant relaxations in rings without endothelium from the control group (3.3±2.6% at 100 µg/ml RWPs, n=4) and those in rings with endothelium were abolished by NG-nitro-L-arginine (30 µM; from 68.2±6.7 to 5.9±3.2% at 100 µg/ml RWPs, n=4). The inhibitory effect of the Ang II treatment on acetylcholine-induced relaxations was prevented by the intake of red wine polyphenols before the infusion of Ang II to rats (Fig. 2A; F=14.2, P<0.0001 Ang II treatment versus RWPs plus Ang II treatment). Intake of red wine polyphenols alone did not affect relaxations to acetylcholine (Fig. 2A). Neither the Ang II treatment nor the red wine polyphenols treatment affected relaxations to sodium nitroprusside in aortic rings without endothelium (Fig. 2C).
|
3.3. Red wine polyphenols prevent the Ang II-induced vascular formation of reactive oxygen species and expression of NADPH oxidase
Previous studies have indicated that the Ang II-induced endothelial dysfunction is associated with an excessive NADPH oxidase-dependent vascular formation of reactive oxygen species, which scavenge NO [15]. Therefore, experiments were performed to test whether the protective effect of red wine polyphenols on the Ang II-induced endothelial dysfunction is associated with a reduced vascular pro-oxidant response as assessed using the redox-sensitive fluorescent probe dihydroethidine. The Ang II treatment caused a marked increase of the low basal fluorescence signal throughout the entire aortic wall (Fig. 3). The stimulatory effect was markedly reduced by the membrane permeant mimetic of superoxide dismutase MnTMPyP and the inhibitor of flavin-dependent enzymes including the NADPH oxidase, diphenylene iodonium whereas it was not affected by the membrane permeant analogue of catalase, polyethyleneglycol catalase (Fig. 4). In contrast to the Ang II treatment, no such increase in fluorescence was observed in intact aortic rings from the red wine polyphenols and Ang II group (Fig. 3). Administration of red wine polyphenols alone did not affect the low basal fluorescence signal (Fig. 3).
|
|
The in vivo Ang II-induced vascular formation of reactive oxygen species has been associated with an upregulation of several NADPH oxidase subunits including p22phox, gp91phox, and nox1 in rats [23]. Moreover, Ang II increased the expression of p22phox, nox1, p40phox, p47phox and p67phox in vascular smooth muscle cells [24,25]. Therefore, the possibility that red wine polyphenols prevent the Ang II-induced vascular expression of NADPH oxidase subunits was assessed by immunohistochemistry. In the control group, a low fluorescent signal for nox1 and p22phox subunits was detected throughout the aortic wall (Figs. 5 and 6
|
|
4. Discussion
The present findings demonstrate that administration of red wine polyphenols in the drinking water effectively prevents the Ang II-induced hypertension in rats. An antihypertensive effect has also been observed after intake of red wine polyphenols in insulin-resistant fructose-fed rats [26] and of a grape skin extract in both L-NAME- and DOCA salt-induced hypertension [11]. Moreover, a grape-derived polyphenol extract accelerated the decrease of systolic blood pressure after cessation of oral intake of L-NAME [11,12]. In addition, polyphenols from cocoa reduced blood pressure in elderly humans with mild isolated hypertension [27] and those from black and green tea attenuated blood pressure in stroke-prone spontaneously hypertensive rats [28]. Altogether, these studies indicate that several polyphenol-rich extracts are able not only to retard effectively the development of hypertension in several experimental models of hypertension but also to normalize blood pressure once hypertension is established in both humans and animals. Although the antihypertensive effect of polyphenols is well established, the mechanism underlying the protective effect still remains to be determined.
Ang II-induced hypertension is associated with an endothelial dysfunction as indicated by the reduced endothelium-dependent relaxation to agonists such as acetylcholine, and an increased vascular formation of reactive oxygen species [15]. An impaired endothelium-dependent relaxation is also observed in patients with essential hypertension [14]. Several lines of evidence support the concept that the vascular pro-oxidant response accounts for the endothelial dysfunction most likely by inactivating NO. Indeed, administration of antioxidants including liposome encapsulated superoxide dismutase, the permeant superoxide dismutase mimetic tempol, vitamin C and vitamin E improved endothelium-dependent relaxation, vascular oxidative stress and hypertension in several experimental models of hypertension and in humans [15,29,30]. Interestingly, the present findings indicate that although the Ang II treatment caused a pronounced impairment of endothelium-dependent relaxations to acetylcholine, those induced by the direct application of red wine polyphenols were maintained. Since relaxations to red wine polyphenols are exclusively mediated by NO in the rat aorta ([31], present findings), these findings strongly suggest that the red wine polyphenols-induced endothelial formation of NO persists in pathologic arteries presenting an oxidative stress. Such an effect may be due to the fact that red wine polyphenols have antioxidant properties thereby preventing the degradation of NO by reactive oxygen species. Indeed, polyphenols can directly interact with superoxide anions and other reactive oxygen species such as hydroxy and peroxy radicals [32–34]. Alternatively, it may also be due to the fact that distinct signaling pathways mediate the stimulatory effect of receptor coupled to G protein activation and polyphenols to endothelial NO synthase activation. Activation of receptors coupled to protein G induce the endothelial formation of NO via the calcium/calmodulin signaling pathway whereas that induced by polyphenols involves the phosphatidylinositol 3-kinase/Akt pathway with the subsequent phosphorylation of Ser1177 of endothelial NO synthase [35,36].
The present study also indicates that intake of red wine polyphenols before the infusion of Ang II prevents the development of an endothelial dysfunction to acetylcholine and the vascular pro-oxidant response. Although the protective effect may be explained, at least in part, by the direct antioxidant properties of polyphenols, it may also be due to changes in the expression pattern of endogenous pro-oxidant and antioxidant enzymes in the arterial wall. Previous studies have indicated a key role of the NADPH oxidase in the endothelial dysfunction, vascular oxidant stress and development of hypertension to Ang II. Indeed, infusion of Ang II to rats increased membrane-bound NADH/NADPH oxidase activity and upregulated the expression of several NADPH oxidase subunits including nox1, nox4 and p22phox in the arterial wall [15,37,38]. Moreover, the hypertensive response to Ang II is markedly blunted in mice deficient in p47phox, a cytosolic subunit of the NADPH oxidase [39]. Consistent with these previous findings are the present ones indicating that the Ang II-treatment caused an upregulation of both p22phox and nox1 proteins in the arterial wall, which was associated with an increased diphenylene iodonium-sensitive formation of superoxide anions. They further indicate that administration of red wine polyphenols to rats prior to the infusion of Ang II prevents vascular oxidative stress and expression of p22phox and nox1. Therefore, the beneficial effect of red wine polyphenols on Ang II-induced hypertension and endothelial dysfunction appears also due to the prevention of the expression of several NADPH oxidase subunits and, hence, the excessive vascular formation of superoxide anions. Previous studies have also shown that tea polyphenols down-regulate the expression of NADPH oxidase subunits p22phox and p67phox in vascular cells, and up-regulate the expression of catalase [28,40]. Although polyphenols prevent oxidative stress in the vascular smooth muscle [41], they are also able to induce a modest pro-oxidant response in endothelial cells, which initiates activation of the phosphatidylinositol 3-kinase/Akt pathway leading to an enhanced formation of NO and endothelium-derived hyperpolarizing factor [35,42–44]. Thus, the dual ability of polyphenols to cause a redox-sensitive formation of vasoprotective endothelial factors and, on the other hand, to prevent excessive vascular oxidative stress via their antioxidant properties, might help to explain their beneficial effect on the cardiovascular system.
In conclusion, the present findings indicate that intake of red wine polyphenols effectively blunts hypertension and endothelial dysfunction induced by the infusion of Ang II to rats. The protective effect is most likely due to the ability of red wine polyphenols to prevent vascular oxidative stress by inhibiting NADPH oxidase expression and to induce an unaltered endothelial formation of NO in pathologic arteries.
| Acknowledgements |
|---|
This study was supported in part by ONIVINS (Ministry of Agriculture, France). The authors are indebted to Dr. M. Grima and C. Coquard (Faculty of Medicine, Strasbourg, France) for the determination of plasma renin activity.
| Notes |
|---|
Time for primary review 32 days
| References |
|---|
|
|
|---|
- St Leger A.S., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet (1979) 1:1017–1020.[Medline]
- Renaud S.C., Gueguen R., Schenker J., d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology (1998) 9:184–188.[CrossRef][ISI][Medline]
- Wollny T., Aiello L., Di Tommaso D., Bellavia V., Rotilio D., Donati M.B., et al. Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production. Br J Pharmacol (1999) 127:747–755.[CrossRef][ISI][Medline]
- Rimm E.B., Williams P., Fosher K., Criqui M., Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 319:1523–1528.
[Abstract/Free Full Text] - Pellegrini N., Pareti F.I., Stabile F., Brusamolino A., Simonetti P. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr (1996) 50:209–213.[ISI][Medline]
- Dell'Agli M., Busciala A., Bosisio E. Vascular effects of wine polyphenols. Cardiovasc Res (2004) 63:593–602.
[Abstract/Free Full Text] - Stoclet J.C., Chataigneau T., Ndiaye M., Oak M.H., El Bedoui J., Chataigneau M., et al. Vascular protection by dietary polyphenols. Eur J Pharmacol (2004) 500:299–313.[CrossRef][ISI][Medline]
- Vinson J.A., Teufel K., Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis (2001) 156:67–72.[CrossRef][ISI][Medline]
- Bentzon J.F., Skovenborg E., Hansen C., Moller J., Saint-Cricq de Gaulejac N., Proch J., et al. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 103:1681–1687.
[Abstract/Free Full Text] - Auger C., Caporiccio B., Landrault N., Teissedre P.L., Laurent C., Cros G., et al. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters (Mesocricetus auratus). J Nutr (2002) 132:1207–1213.
[Abstract/Free Full Text] - Soares de Moura R., Costa Viana F.S., Souza M.A.V., Kovary K., Guedes D.C., Oliviera E.P.B., et al. Antihypertensive, vasodilator and antioxidant effects of vinifera grape-skin extract. J Pharm Pharmacol (2002) 54:1515–1520.[CrossRef][ISI][Medline]
- Bernatova I., Pechanova O., Babal P., Kysela S., Stvrtina S., Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol (2002) 282:H942–H948.
[Abstract/Free Full Text] - Mombouli J.V., Vanhoutte P.M. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol (1999) 31:61–74.[CrossRef][ISI][Medline]
- Taddei S., Virdis A., Ghiadoni L., Magagna A., Pasini A.F., Garbin U., et al. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. J Hypertens (2001) 19:1379–1386.[CrossRef][ISI][Medline]
- Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest (1996) 97:1916–1923.[ISI][Medline]
- Miller F.J. Jr., Gutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res (1998) 82:1298–1305.
[Abstract/Free Full Text] - Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin: II. Proc Natl Acad Sci U S A (1997) 94:14483–14488.
[Abstract/Free Full Text] - Shinozaki K., Ayajiki K., Nishio Y., Sugaya T., Kashiwagi A., Okamura T. Evidence for a causal role of the renin–angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension (2004) 43:255–262.
[Abstract/Free Full Text] - Kurz S., Hink U., Nickenig G., Borthayre A.B., Harrison D.G., Munzel T. Evidence for a causal role of the renin–angiotensin system in nitrate tolerance. Circulation (1999) 99:3181–3187.
[Abstract/Free Full Text] - Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin–angiotensin system in vitro and in vivo. Free Radic Biol Med (2001) 31:1456–1464.[CrossRef][ISI][Medline]
- Andriambeloson E., Magnier C., Haan-Archipoff G., Lobstein A., Anton R., Beretz A., et al. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr (1998) 128:2324–2333.
[Abstract/Free Full Text] - Ingert C., Grima M., Coquard C., Barthelmebs M., Imbs J.L. Effects of dietary salt changes on renal renin–angiotensin system in rats. Am J Physiol Renal Physiol (2002) 283:F995–F1002.
[Abstract/Free Full Text] - Lassegue B., Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol (2003) 285:R277–R297.
[Abstract/Free Full Text] - Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res (2001) 88:888–894.
[Abstract/Free Full Text] - Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin: II. Circ Res (2002) 90:1205–1213.
[Abstract/Free Full Text] - Al-Awwadi N., Azay J., Poucheret P., Cassanas G., Krosniak M., Auger C., et al. Antidiabetic activity of red wine polyphenolic extract, ethanol, or both in streptozotocin-treated rats. J Agric Food Chem (2004) 52:1008–1016.[CrossRef][ISI][Medline]
- Taubert D., Berkels R., Roesen R., Klaus W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA (2003) 290:1029–1030.
[Free Full Text] - Negishi H., Xu J.W., Ikeda K., Njelekela M., Nara Y., Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr (2004) 134:38–42.
[Abstract/Free Full Text] - Kawada N., Imai E., Karber A., Welch W.J., Wilcox C.S. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol (2002) 13:2860–2868.
[Abstract/Free Full Text] - Chen X., Touyz R.M., Park J.B., Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension (2001) 38:606–611.
[Abstract/Free Full Text] - Andriambeloson E., Kleschyov A.L., Muller B., Beretz A., Stoclet J.C., Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol (1997) 120:1053–1058.[CrossRef][ISI][Medline]
- Hu S., Sheng W.S., Peterson P.K., Chao C.C. Cytokine modulation of murine microglial cell superoxide production. Glia (1995) 13:45–50.[CrossRef][ISI][Medline]
- Torel J., Cillard P. Antioxidant activity of flavonoids and reactivity with proxy radical. Phytochemistry (1986) 25:383–387.[CrossRef][ISI]
- Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet (1993) 341:454–457.[CrossRef][ISI][Medline]
- Ndiaye M., Chataigneau M., Lobysheva I., Chataigneau T., Schini-Kerth V.B. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J (2005) 19:455–457.
[Abstract/Free Full Text] - Fleming I., Busse R. Signal transduction of eNOS activation. Cardiovasc Res (1999) 43:532–541.
[Abstract/Free Full Text] - Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers Q., Taylor W.R., et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res (1997) 80:45–51.
[Abstract/Free Full Text] - Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res (2002) 90:E58–E65.[CrossRef][ISI][Medline]
- Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin: II. Hypertension (2002) 40:511–515.
[Abstract/Free Full Text] - Ying C.J., Xu J.W., Ikeda K., Takahashi K., Nara Y., Yamori Y. Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. Hypertens Res (2003) 26:823–828.[CrossRef][ISI][Medline]
- Oak M.H., Chataigneau M., Keravis T., Chataigneau T., Beretz A., Andriantsitohaina R., et al. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler Thromb Vasc Biol (2003) 23:1001–1007.
[Abstract/Free Full Text] - Ndiaye M., Chataigneau T., Andriantsitohaina R., Stoclet J.C., Schini-Kerth V.B. Red wine polyphenols cause endothelium-dependent EDHF-mediated relaxations in porcine coronary arteries via a redox-sensitive mechanism. Biochem Biophys Res Commun (2003) 310:371–377.[CrossRef][ISI][Medline]
- Ndiaye M., Chataigneau T., Chataigneau M., Schini-Kerth V.B. Red wine polyphenols induce EDHF-mediated relaxations in porcine coronary arteries through the redox-sensitive activation of the PI3-kinase/Akt pathway. Br J Pharmacol (2004) 142:1131–1136.[CrossRef][ISI][Medline]
- Duarte J., Andriambeloson E., Diebolt M., Andriantsitohaina R. Wine polyphenols stimulate superoxide anion production to promote calcium signaling and endothelial-dependent vasodilatation. Physiol Res (2004) 53:595–602.[ISI][Medline]
This article has been cited by other articles:
![]() |
P. Castilla, A. Davalos, J. L. Teruel, F. Cerrato, M. Fernandez-Lucas, J. L. Merino, C. C. Sanchez-Martin, J. Ortuno, and M. A Lasuncion Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1053 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lopez-Sepulveda, R. Jimenez, M. Romero, M. J. Zarzuelo, M. Sanchez, M. Gomez-Guzman, F. Vargas, F. O'Valle, A. Zarzuelo, F. Perez-Vizcaino, et al. Wine Polyphenols Improve Endothelial Function in Large Vessels of Female Spontaneously Hypertensive Rats Hypertension, April 1, 2008; 51(4): 1088 - 1095. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







